Quote Originally Posted by Rjk View Post
I know a bit about the regulatory requirements as well, why do you think we are better doing our own thing?
if we had different regulatory requirements to the EU then nobody is going to target our market first, they would go for the EU first then look at what they would need to do to launch in the smaller markets afterwards
Assuming no deal Brexit we will have different licensing and MHRA will be responsible for approval new medicines and issuing MAs. The UK gov is setting about streamlining the UK approval process so it may be that we give approval for Covid vaccines ahead of the EU. EMA will no longer be in control of UK.

Pharma will launch first in markets that give earliest approvals. They will also have a commitment to pre-orders as and when approval is granted. UK is an attractive market as it is a reference point for many countries for approvals and price.

Also the manufacture and distribution will be phased, it's not as if they will drop 400m doses off at a warehouse in Germany.